You are here

Coronavirus Outbreak

We thank our member companies for their continued efforts to mobilize for health care workers on the frontlines. Learn more about how the industry has come together in the fight against COVID-19.

Coronavirus Top News

Press Release | September 22, 2020
WASHINGTON, D.C. – As part of the medtech industry’s ongoing mobilization to combat COVID-19, the Advanced Medical Technology Association (AdvaMed) today announced that the U.S. Agency for International Development (USAID) has approved a multi-year partnership under which the association will provide private sector resources and expertise to help increase adoption of medical technology-specific international regulatory standards and good regulatory practices by governments across Latin America, Africa, and Southeast Asia.
Press Release | September 17, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million, based on the latest data from the association’s COVID-19 testing supply registry.
Press Release | August 20, 2020
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement: “AdvaMed fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle is core to the industry’s long-standing call for a modernization of the regulatory framework for all diagnostic tests, both commercial in vitro diagnostics (IVDs) developed and manufactured by AdvaMed members, and laboratory developed tests (LDTs)."

More news

AdvaMed Members Fight Coronavirus

Since the onset of the coronavirus (COVID-19) outbreak, AdvaMed member companies have donated millions of dollars’ worth of medical products and cash to hospitals, foundations and charities around the world. Medical device companies are responding to increased demand by ramping up production wherever possible, coordinating closely with governments to ensure the delivery of supplies where they are most needed, and in some cases, creating new devices and diagnostic tests to help effectively diagnose and treat sick patients.

We have assembled a collection of some of the efforts undertaken by AdvaMed member companies based on public statements.

Read more

In Vitro Diagnostic COVID-19 Tests

In vitro diagnostic (IVD) manufacturers have taken key steps to increase patient access to coronavirus diagnostic testing in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health. To further assist state and federal governments in their pandemic responses, AdvaMed has created a comprehensive, national COVID-19 diagnostic supply registry which compiles information from diagnostic companies along with publicly available data on daily tests performed to create a centralized and standardized COVID-19 diagnostic supply registry.

Learn about the Registry

We have also compiled a list of companies that have developed IVDs that have received Emergency Use Authorization from the U.S. Food and Drug Administration.

View the list

Diagnostics Resources

MedTech’s Role in Combatting COVID-19

The medical technology industry recognizes its crucial role in our nation’s health care system, particularly during an unprecedented public health emergency such as the COVID-19 pandemic. This crisis has united us all as Americans in a global fight. The patients our industry serves have always been our No. 1 priority, and we are working around the clock to meet their needs. We are committed as medical technology innovators and manufacturers to working with federal, state, and local authorities to ensure our nation’s disaster planning efforts are coordinated, efficient, and effective. For weeks now, the medtech industry has been mobilizing to this global cause, and we are committed to the following guiding principles in our efforts to conquer the coronavirus.

Read more

Coronavirus Task Force

AdvaMed is actively working with key U.S. government agencies – including HHS, FDA, and CDC – as well government agencies around the world, to identify how the industry can help ensure that providers and patients everywhere have access to the medical technologies they need to help diagnose and fight this deadly virus.

As we continue to assess and respond to a crisis that continues to evolve, AdvaMed’s objective is to pool and disseminate industry knowledge, and share developments among our membership.

To that end, AdvaMed has assembled a coronavirus task force. Any AdvaMed member company is eligible to join. This task force meets during scheduled conference calls and provides readouts on the latest intel we are receiving from AdvaMed members, government agencies and other stakeholders.

Join the Task Force

Mobilize For MedTech

Mobilize for MedTech is AdvaMed’s grassroots campaign, working to ensure that patients have timely access to life-changing technologies. Sign up to receive regular updates: